Factors to consider when designing clinical trials for repurposed drugs
Expert Review of Clinical Pharmacology · 03.06.2026 · 19 (6) · 509-519
DOI: 10.1080/17512433.2026.2671276 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Expert Review of Clinical Pharmacology, online erschienen am 08.05.2026. Verfasst von Samuel Gordon und 2 weiteren Autor:innen. Beteiligte Einrichtung: Research Ethics in Medicine Study Group (REMEDY), Department of Bioethics and Health Psychology, Faculty of Health Sciences, Jagiellonian University …. Hauptthemen laut MEDLINE: Drug Repositioning, Research Design, Drug Development, Clinical Trials as Topic. Die Arbeit nennt 81 Literaturangaben. Gefördert von: National Science Centre, Foundation for Polish Science.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Research Ethics in Medicine Study Group (REMEDY), Department of Bioethics and Health Psychology, Faculty of Health Sciences, Jagiellonian University Medical College, Krakow, Poland.
Förderung
- National Science Centre
- Foundation for Polish Science
Zitieren
APA
Gordon, S., Klas, K., & Waligora, M. (2026). Factors to consider when designing clinical trials for repurposed drugs. Expert Review of Clinical Pharmacology, 19(6), 509-519. https://doi.org/10.1080/17512433.2026.2671276
Vancouver
Gordon S, Klas K, Waligora M. Factors to consider when designing clinical trials for repurposed drugs. Expert Review of Clinical Pharmacology. 2026;19(6):509-519. doi:10.1080/17512433.2026.2671276
BibTeX
@article{Gordon2026,
author = {Gordon, Samuel and Klas, Katarzyna and Waligora, Marcin},
title = {Factors to consider when designing clinical trials for repurposed drugs},
journal = {Expert Review of Clinical Pharmacology},
year = {2026},
volume = {19},
number = {6},
pages = {509--519},
doi = {10.1080/17512433.2026.2671276}
}
EUVIMED